We compared an acellular (B type) pertussis-component diphtheria-tetanuspertussis (DTP-
Ac) vaccine containing equal amounts of filamentous hemagglutinin and lymphocytosis …

This is the first study in children from the United States that evaluates the immunogenicity of
and adverse reactions to the Connaught/Biken two-component acellular pertussis vaccine …

Objective. To compare the safety and immunogenicity of a variety of acellular (AC) and
whole-cell (WC) pertussis vaccines combined with diphtheria and tetanus toxoids. Methods …

Objective. To evaluate the immunogenicity and reactogenicity of an acellular pertussis
vaccine (pa) either formulated with diphtheria and tetanus toxoids (dTpa) or administered …

Healthy 17-to 24-month-old children, previously immunized with three doses of whole-cell
diphtheria-tetanus-pertussis (DTP) vaccine, were enrolled in a multicenter double-blind …

The safety and immunogenicity of two formulations of an acellular pertussis vaccine as a
booster at 17 to 19 months of age were assessed in children immunized at 2, 4 and 6 …

A second generation acellular pertussis vaccine (component pertussis vaccine) containing
purified pertussis toxin (PT) and filamentous hemagglutinin (FHA) was tested for its …

The safety and immunogenicity of a booster dose of a new acellular pertussis component
diphtheria-tetanus toxoids-pertussis vaccine (DTaP) were compared with whole cell …

Diphtheria-tetanus-acellular pertussis vaccines have been licensed in the United States
since 1991. Compared with the whole cell pertussis component diphtheria-tetanus-pertussis …

In an effort to determine the optimal dose of pertussis toxoid (PT) and filamentous
haemagglutinin (FHA) for use in acellular pertussis vaccines we compared the …